1 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
2 Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
3 School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
4 Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland.
5 HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland.
6 Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK.
7 Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
8 Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.
9 Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
10 Institute of Comparative Economic Studies, Hosei University Tokyo, Japan.
11 Department of Global Health Economics and Policy, University of Kragujevac, Serbia.
12 Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.
13 Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania.
14 Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria.
15 Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
16 Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
17 Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina.
18 Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria.
19 State Institute for Drug Control, Prague, Czech Republic.
20 Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic.
21 State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia.
22 Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany.
23 Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary.
24 Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary.
25 Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo.
26 Independent Consultant, Riga, Latvia.
27 Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
28 Department of Health Services Management, University of Malta, Valletta, Malta.
29 Medicines Committee, Oslo University Hospitals, Oslo, Norway.
30 Faculty of Medicine, Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania.
31 Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia.